Article
Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer.
PloS one - 1 Jan 2012
Méplan Catherine, Rohrmann Sabine, Steinbrecher Astrid, Schomburg Lutz, Jansen Eugène, Linseisen Jakob, Hesketh John
Abstract excerpt
Increased dietary intake of Selenium (Se) has been suggested to lower prostate cancer mortality, but supplementation trials have produced conflicting results. Se is incorporated into 25 selenoproteins. The aim of this work was to assess whether risk of prostate cancer is affected by genetic variants in genes coding for selenoproteins, either alone or in combination with Se status. 248 cases and 492 controls from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
